Pacer Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-786
Closed -$5.45K 2637
2024
Q2
$5.45K Sell
786
-558
-42% -$3.92K ﹤0.01% 3629
2024
Q1
$10.3K Buy
+1,344
New +$10.8K ﹤0.01% 3530
2018
Q4
Sell
-48,068
Closed -$297K 843
2018
Q3
$297K Buy
48,068
+40,467
+532% +$183K 0.01% 955
2018
Q2
$49K Buy
7,601
+4,704
+162% +$33.5K ﹤0.01% 1116
2018
Q1
$20K Sell
2,897
-753
-21% -$8.77K ﹤0.01% 1014
2017
Q4
$46K Buy
+3,650
New +$44.5K ﹤0.01% 1025

Other funds holding MDXG

Pacer Advisors's MDXG Position: Q3 2024 in Review

Pacer Advisors sold out of MiMedx Group (MDXG) in Q3 2024, closing a stake of 786 shares — an estimated $5.45K sold.

Pacer Advisors first reported a position in MDXG in Q4 2017 and held it in 6 quarters. The position peaked at $297K in Q3 2018. 194 funds tracked by Wall St. Rank hold MDXG as of Q3 2024.

  • Pacer Advisors reported no remaining MiMedx Group position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 786 MiMedx Group shares in Q3 2024, an estimated $5.45K.
  • Pacer Advisors first reported a position in MiMedx Group in Q4 2017 and held it in 6 quarters.
  • Pacer Advisors's MiMedx Group position peaked at $297K in Q3 2018.
  • 194 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.